Diet and Exercise in Pompe Disease
NCT02363153 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2
Last updated 2021-05-14
Summary
This study examines the effects of individualized diet and exercise plans on muscle strength, quality of life and respiratory function in Pompe disease. Subjects will be given a diet and exercise plan based on their individual needs, which will be followed for 16 weeks. Participants will also be provided with an activity tracker in order to track their exercise activities, access to an app that will allow them to input their daily food intake, and they will also come to the University of Florida for exercise tests, respiratory tests and questionnaires.
Conditions
- Pompe Disease
- Glycogen Storage Disease Type II
- Lysosomal Storage Diseases
Interventions
- OTHER
-
Diet and Exercise
Exercise will consist of 2x/week aerobic exercise, 2x/week strength training and 1x/week core-stabilizing exercise. Diet will be constructed so that 30% of the daily caloric goal will be protein, 35% fat, and 35% carbohydrates.
Sponsors & Collaborators
-
Amicus Therapeutics
collaborator INDUSTRY -
University of Florida
lead OTHER
Principal Investigators
-
Manuela Corti, PT, PhD · University of Florida
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 15 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-11-06
- Primary Completion
- 2021-05-12
- Completion
- 2021-05-12
Countries
- United States
Study Locations
More Related Trials
-
Twice Weekly Steroids and Exercise as Therapy for DMD
NCT04322357 ·Status: COMPLETED ·Phase: PHASE2
-
Energy Supplements to Improve Exercise Tolerance in Metabolic Myopathies
NCT02448667 ·Status: COMPLETED ·Phase: NA
-
Comparative Study of Strategies for Management of Duchenne Myopathy (DM)
NCT03633565 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effects of Exercise Versus Inactivity on People With Mitochondrial Muscle Disease
NCT00457314 ·Status: UNKNOWN ·Phase: PHASE2
-
Study to Evaluate Efficacy and Safety in Chinese Patients With Late Onset Pompe Disease With Alglucosidase Alfa Treatmen
NCT04676373 ·Status: COMPLETED ·Phase: PHASE4
-
Natural History Study of Mitochondrial Myopathy
NCT05250375 ·Status: RECRUITING
-
Assessment of Energy Metabolism in Metabolic Myopathies
NCT07268287 ·Status: COMPLETED ·Phase: NA
-
A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of PF-06252616 in Duchenne Muscular Dystrophy
NCT02310763 ·Status: TERMINATED ·Phase: PHASE2
-
Exploratory Muscle Biopsy Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa
NCT01288027 ·Status: COMPLETED ·Phase: PHASE4
-
A Pharmacokinetic Study of Oral Deflazacort in Children and Adolescent Subjects With Duchenne Muscular Dystrophy
NCT02251600 ·Status: COMPLETED ·Phase: PHASE1
-
Exploratory Study of NS-065/NCNP-01 in DMD
NCT02081625 ·Status: COMPLETED ·Phase: PHASE1
-
Exploring the Physiologic, Pharmacodynamic, and Clinical Responses of Skeletal Muscle in Patients With Spinal Muscular Atrophy Treated With SMN-Directed Therapies
NCT06532474 ·Status: RECRUITING
-
Pompe Disease QMUS and EIM
NCT02742298 ·Status: COMPLETED ·Phase: NA
-
Aerobic Training in Patients With Congenital Myopathies
NCT02020187 ·Status: COMPLETED ·Phase: NA
-
Natural History Study of Oculopharyngeal Muscular Dystrophy
NCT03161847 ·Status: WITHDRAWN
-
Phase III Randomized, Double-Blind Study of Prednisone for Duchenne Muscular Dystrophy
NCT00004646 ·Status: COMPLETED ·Phase: PHASE3
-
Fat and Glucose Metabolism in Fed and Fasted State in Patients With Low Skeletal Muscle Mass
NCT03970135 ·Status: COMPLETED ·Phase: NA
-
Safety, Tolerability, and Efficacy of MTP-131 for the Treatment of Mitochondrial Myopathy
NCT02367014 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Routine Health Care of Patients With FSHD
NCT02622438 ·Status: COMPLETED ·Phase: NA
-
Clinical Outcome Measures in Myotonic Dystrophy Type 2
NCT03603171 ·Status: COMPLETED
-
Improved Muscle Function in Duchenne Muscular Dystrophy Through L-Arginine and Metformin
NCT02516085 ·Status: COMPLETED ·Phase: PHASE1
-
A Prospective Natural History Study of Progression of Subjects With Duchenne Muscular Dystrophy.
NCT01753804 ·Status: TERMINATED
-
Evaluation of a Mechanical Device During Acute Respiratory Failure in Patients With Neuromuscular Disorders
NCT00839033 ·Status: TERMINATED ·Phase: PHASE3
-
An MRI Study on Muscular Diseases -Pompe Disease and Dystrophia Myotonica-
NCT02708784 ·Status: UNKNOWN
-
Investigating Exercise in Myotonic Dystrophy Type 2 (DM2)
NCT06716931 ·Status: RECRUITING ·Phase: NA